The Journal of Prevention of Alzheimer's Disease
Evoke (+) trials of semaglutide for early alzheimer's disease: Innovations, lessons, and implications
Trial in peopleSemaglutide
Papers by Jeffrey L. Cummings
14 results
- Nature Reviews Neurology
Symptomatic treatment for Alzheimer disease: current evidence and future directions
ReviewInterventions - AAIC 2025 Abstract
Evaluation of Biomarkers in Active Alzheimer's Disease Intervention Clinical Trials – The Biomarker Observatory
Computational studyBiomarkers - AAIC 2025 Abstract
The utility of plasma p ‐tau217 in former American football players at risk for chronic traumatic encephalopathy
Study in peopleBiomarkers
- AAIC 2025 Abstract
Endophenotype‐based in silico network medicine methodology for rational design of drug combination in Alzheimer's disease
Computational studyInterventions - AAIC 2025 Abstract
TRONTIER 1 and TRONTIER 2: Pivotal trials of trontinemab in early symptomatic Alzheimer’s disease
Trial in peopleInterventions - AAIC 2025 Abstract
Single‐cell digital twins identify drug targets and repurposable medicine in Alzheimer’s disease
Computational studyAI & data - AAIC 2025 Abstract
Synergies between Small RNA and Protein Biomarkers for Early Detection of Cognitive Impairment – results from EPAD
Trial in peopleBiomarkers